Felipe K Hurtado

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Photodynamic Therapy

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto A Chiappori, Benjamin C Creelan, Tawee Tanvetyanon, Jhanelle E Gray, Eric B Haura, Ram Thapa, Margaret L Barlow, Zhihua Chen, Dung Tsa Chen, Amer A Beg, Theresa A Boyle, Julio Castro, Liza Morgan, Erick J Morris, Mehreteab Aregay, Felipe K Hurtado, Luigi Manenti, Scott Antonia
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, Martin J Van Den Bent, Heather A Wakelee, Patrick Y Wen, Chao-Hua Chiu, Sergey Orlov, Rita Chiari, Margarita Majem Tarruella, Mark McKeage, Chong-Jen Yu, Pilar Garrido Lopez, Felipe K Hurtado, Pilar Cazorla Arratia, Yuanbo Song, Fabrice Branle, Michael Shi, Dong Wan Kim
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Felipe K Hurtado, Filippo de Braud, Javier De Castro Carpeño, Maria Jose de Miguel Luken, Ding Wang, Jeffrey Scott, Yvonne Y Lau, Tracey McCulloch, Morten Mau Sorensen
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors. Cancer chemotherapy and pharmacology 87 (4) (2021)